RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 136 filers reported holding RELAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,347,357 | +5.3% | 279,115 | +57.2% | 0.02% | +13.3% |
| Q2 2023 | $2,229,441 | +138.5% | 177,503 | +183.7% | 0.02% | +200.0% |
| Q4 2022 | $934,646 | -19.6% | 62,560 | +20.5% | 0.01% | -28.6% |
| Q3 2022 | $1,162,000 | +17.1% | 51,934 | -12.3% | 0.01% | +16.7% |
| Q2 2022 | $992,000 | +91.5% | 59,220 | +242.4% | 0.01% | +50.0% |
| Q1 2022 | $518,000 | +120.4% | 17,298 | +126.3% | 0.00% | +100.0% |
| Q4 2021 | $235,000 | -88.8% | 7,645 | -88.5% | 0.00% | -92.3% |
| Q3 2021 | $2,091,000 | +104.6% | 66,318 | +137.4% | 0.03% | +116.7% |
| Q2 2021 | $1,022,000 | +2.7% | 27,933 | -3.0% | 0.01% | -7.7% |
| Q1 2021 | $995,000 | +45.9% | 28,787 | +75.5% | 0.01% | +44.4% |
| Q4 2020 | $682,000 | +10.4% | 16,400 | +13.0% | 0.01% | 0.0% |
| Q3 2020 | $618,000 | – | 14,519 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |